Myrtelle
Wakefield, MA
Myrtelle is a gene therapy company that offers clinical trials for the treatment of rare monogenetic disorders. It helps in addressing an array of diseases with white matter involvement that includes demyelinating diseases and ASPA-associated disorders with rare CNS diseases. It also helps healthcare professionals to develop and deliver noveltreatments for devastating disorders of the central nervous system and transform the treatment of neurological diseases that improve the quality of life and longevity.The company's mission is to develop and deliver novel treatments for devastating disorders of the central nervous system, beginning with its lead program, gene therapy treatment for Canavan disease.It was founded in 2020 and is headquartered in Wakefield, Massachusetts.
myrtellegtx.comCompany Details
Founded
- 2020
Employees
- Between 10 - 50 employees
Raised
- $27,025,000
Headquarters Location
- Wakefield, MA
Public
- No
Acquired
- No
CEO
Adrian Stecyk
Company Collections
These are collections Myrtelle is a part of. Click on the collection name to view similar companies.
Myrtelle's Industries
Myrtelle Headquarters Location
Total Amount Raised: $27,025,000
Myrtelle Funding Rounds
Debt Financing
$7,485,000
Debt Financing
$6,040,000
Series Unknown
$13,500,000
Series Unknown Investors
Panacea Venture
Myrtelle Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Myrtelle.